jonathan a. schechter, p.c.

111 eighth avenue
new york, new york 10011

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 27, 2013

NYS DOS ID#
4424161

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION

Name History
2013 - JONATHAN A. SCHECHTER, P.C.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Mark Schechter is the pawnbroker for the ultra-rich
    By John Aidan Byrne - Sunday Sep 17, 2017

    Mark Schechter is Wall Street’s pawnbroker of exclusive bling — and his business is booming. Brokers, traders and financial tycoons are some of his super wealthy clients. And these high-rollers are eager to exchange their rare, multimillion-dollar diamonds, Tiffany jewelry and Cartier watches for short-term loans of $2,500 to $1 million, or for quick cash...

    Source: New York Post: Business
  • DataCamp Nabs $4M for Data Science Courses, Moves to NY
    By Jeff Engel - Thursday Jul 27, 2017

    Data scientists remain in high demand. But these days, many types of professionals can boost their career prospects if they have at least a basic level of “data literacy,” says Jonathan Cornelissen. That’s part of the reason why he says his online education company, DataCamp, has been growing over the past couple of years. DataCamp, […]

    Source: Xconomy New York
  • Jonathan Casillas: Fear of police has led to anthem protests
    By Paul Schwartz - Friday Sep 29, 2017

    Jonathan Casillas hopes he can remain in the NFL a few more years, four or five if he is lucky. When his career is over, he will be a former NFL player. “But at the end of the day,’’ he said, “I’m still gonna be a black man in America.’’ It is for this reason,...

    Source: New York Post: Sports
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York